TEVA Stock

Is Teva Pharmaceutical (TEVA) Stock Worth Buying After Announcing An Increase of 1% In Its Revenue?

Teva Pharmaceutical (NYSE: TEVA) stock was up by 12% on Wednesday. A week ago, the stock hit a new low this year, but now, this stock seems to have ended its downtrend. So, is it time to buy the stock now? - July 29, 2021

Will Teva Pharmaceutical (TEVA) Shares Rise Sharply After Its Seffalair And BroPair Spiromax Receive Approval In EU?

Analyst Elliot Wilbur gave a buy rating on the stock three days ago but did not assign any price target. - April 08, 2021

Is Corteva Stock a Buy Right Now? | The Motley Fool

What's the investment case for the agriscience stock as the company's management comes under pressure from activist investor Starboard Value? - March 04, 2021

Is Teva Pharmaceuticals a Safe Stock to Buy Now? | The Motley Fool

The largest generic drug manufacturer in the world can be bought for pennies on the dollar. - February 21, 2021

TEVA Stock Declines Despite Q4 Earnings and Sales Beat

TEVA beats on fourth-quarter earnings and sales. It issues its financial guidance for 2021. Stock down. - February 11, 2021